Enfortumab-Vedotin

Very useful and its efficacy was found to be the best, maybe in the next years it'll  become the first line of treatment, but for now the approvational studies suggests to use it after immunotherapy

Map: A patient with Urothelial cancer (1038)
Node: 19691
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway